RT Journal Article
SR Electronic
T1 The spatial percept of tinnitus is associated with hearing asymmetry: subgroup comparisons
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.05.20073999
DO 10.1101/2020.05.05.20073999
A1 Eleni Genitsaridi
A1 Theodore Kypraios
A1 Niklas K. Edvall
A1 Natalia Trpchevska
A1 Barbara Canlon
A1 Derek J. Hoare
A1 Christopher R. Cederroth
A1 Deborah A. Hall
YR 2020
UL http://medrxiv.org/content/early/2020/05/08/2020.05.05.20073999.abstract
AB The spatial percept of tinnitus is hypothesized as an important variable for tinnitus subtyping. Hearing asymmetry often associates with tinnitus laterality, but not always. One of the methodological limitations for cross-study comparisons is how the variables for hearing asymmetry and tinnitus spatial perception are defined. In this study, data from two independent datasets were combined (n= 833 adults, age ranging from 20 to 91 years, 404 males, 429 females) to investigate characteristics of subgroups with different tinnitus spatial perception focusing on hearing asymmetry. Three principle findings emerged. First, a hearing asymmetry variable emphasizing the maximum interaural difference most strongly discriminated unilateral from bilateral tinnitus. Merging lateralized bilateral tinnitus (perceived in both ears but worse in one side) with unilateral tinnitus weakened this relationship. Second, there was an association between unilateral tinnitus and ipsilateral asymmetric hearing. Third, unilateral and bilateral tinnitus were phenotypically distinct, with unilateral tinnitus being characterized by older age, asymmetric hearing, more often wearing one hearing aid, older age at tinnitus onset, shorter tinnitus duration, and higher percentage of time being annoyed by tinnitus. We recommend that careful consideration is given to the definitions of hearing asymmetry and tinnitus spatial perception in order to improve the comparability of findings across studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement number 722046 and the GENDER-Net Co-Plus Fund (GNP-182). CRC received research funding from Decibel Therapeutics, Inc. DH is an NIHR Senior Investigator.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPlease contact the corresponding author [EG] for queries about accessing the data that support the findings of this study. Restrictions apply to the availability of these data, which were used under license for this study.